Target intelligence / Profile preview

Muscle-type alpha-1-beta-1-gamma-delta nicotinic acetylcholine receptor (fetal nAChR)

Target
fetal nAChR
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor, Cholinergic receptor, Nicotinic acetylcholine receptor
01

Overview

The muscle-type alpha-1-beta-1-gamma-delta nicotinic acetylcholine receptor is a pentameric ligand-gated ion channel that serves as the primary mediator of neuromuscular transmission in the developing fetus and in denervated adult muscle (Wikipedia, 2024; PMC, 2009). It is composed of two alpha-1 subunits and one each of the beta-1, gamma, and delta subunits, distinguishing it from the adult isoform which contains an epsilon subunit instead of the gamma subunit (Wikipedia, 2024; PMC, 2011). Upon binding of the neurotransmitter acetylcholine to its extracellular sites, the receptor undergoes a conformational change that opens a central pore, allowing the influx of cations such as sodium and calcium, which leads to muscle fiber depolarization and subsequent contraction (ResearchGate, 2007; PubMed, 1994). This receptor is a critical target in the pathogenesis of myasthenia gravis, where autoantibodies—some specifically targeting the fetal gamma subunit—cause receptor loss and impaired synaptic signaling (PMC, 2012; MDPI, 2023). Pharmacologically, it is the site of action for neuromuscular blocking agents used in clinical anesthesia, including competitive antagonists like pancuronium and depolarizing agonists like succinylcholine, as well as various potent neurotoxins from snake and cone snail venoms (PubMed, 2002; MDPI, 2024). Understanding the distinction between the fetal and adult forms is essential for diagnosing neonatal myasthenia and developing subtype-specific therapeutic interventions (Frontiers, 2025; eMedicine, 2025).

Other names
Fetal muscle-type nicotinic acetylcholine receptorEmbryonic muscle-type nicotinic acetylcholine receptor(alpha-1)2-beta-1-gamma-delta nAChRExtrajunctional nicotinic acetylcholine receptorCHRNA1-CHRNB1-CHRNG-CHRND complex
02

Mechanism of action

Agonist binding to the extracellular domain (specifically at the alpha-gamma and alpha-delta subunit interfaces) induces a conformational change that opens a central cation-selective pore. This allows the influx of sodium and calcium ions and the efflux of potassium ions, leading to membrane depolarization of the motor endplate and triggering muscle contraction.

03

Biological functions

Neuromuscular transmissionMuscle contractionIon transportSynaptic signaling
04

Disease associations

Myasthenia gravisArthrogryposis multiplex congenitaFetal akinesia deformation sequenceMuscle paralysis
05

Safety considerations

Respiratory failure due to diaphragmatic paralysisNeuromuscular blockadeReceptor desensitizationRisk of hyperkalemia with depolarizing blockers in denervated muscle
06

Interacting drugs

Acetylcholine

9 more in the full profile.

07

Biomarkers

Anti-AChR binding antibodiesAnti-AChR blocking antibodiesAnti-AChR modulating antibodiesAnti-fetal AChR antibodies

Beyond the preview

Go deeper on Muscle-type alpha-1-beta-1-gamma-delta nicotinic acetylcholine receptor (fetal nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscle-type alpha-1-beta-1-gamma-delta nicotinic acetylcholine receptor (fetal nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call